logo
logo
Sign in
Emma Jackson
Followers 1 Following 0
Emma Jackson 2020-10-14
img

OverviewVaginal sling procedures are defined as types of surgeries that can help to control stress urinary incontinence.

A new report on the global vaginal slings market, published by Market Research Future (MRFR), infers that this market could mark improvement at 3.6 % CAGR between 2017 and 2023.

In terms of value, the market can be worth USD 1,459 Mn by the end of the forecast period.Major market drivingVaginal Slings Market  factors of the global vaginal slings market include the aging female population, increasing research to discover new urinary incontinence treatment options, rising occurrence of urinary incontinence.

However, the complications caused by urinary incontinence surgery and various recent product recall can hinder the market growth.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7888Market SegmentationThe global vaginal slings market segmentation encompasses end-user, method, and product type.

MRFR’s take on the market explores various facets of the market in-depth.Regarding end-users, this market has been segmented into ambulatory surgery centers, hospitals, urogynecology clinics, and others.

The TVT segment holds the 52% market share in the global vaginal slings market.Regional SegmentationA geographical outlining of the global vaginal slings market covers Europe, The Americas (North America & Latin America), Asia Pacific, and the Middle East & Africa (MEA).During the forecast period, the Americas region is expected to hold the largest market share in the global market due to the increasing awareness and the rising prevalence of urinary incontinence among the female population.

collect
0
Emma Jackson 2020-10-14
img

The global drug discovery informatics market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period.

Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R) expenditure, and increasing burden of chronic diseases.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7831Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth.

On the basis of region, the Americas is expected to hold higher market share over the forecast period pertaining to the presence of market value contributors, burgeoning pharmaceutical and biotechnology vertical, and rising prevalence of chronic diseases in the US and Canada.

For instance, as per statistics published by the Center for Disease Control and Prevention (CDC), about 610,000 people die due to heart disease in the US every year (one in every four deaths).Europe would follow the Americas in terms of value in the drug discovery informatics market owing to a surge in the clinical discovery ventures coupled with various activities conducted by research institutes, universities, and centers.

The federal government acts as a regulator and also insures some public employees in Germany.

The German government also proposes many healthcare programs to make citizens aware of the fatal disease.Asia-Pacific would represent the fastest market growth during the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region.The Middle East & Africa has the least share of the global drug discovery informatics market.

collect
0
Emma Jackson 2020-10-14
img

Market HighlightsThe Global Fluoroscopy and Mobile C-Arms Market is expected to register a CAGR of 4.58% and is anticipated to reach USD 2,951.4 million by 2023.

Fluoroscopy and mobile c-arms systems are used in a broad range of interventional radiological procedures, especially in the treatment of conditions such as spinal cord injury, pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other disease ailments.The rising prevalence of chronic diseases, growing geriatric population, and rising adoption of fluoroscopy in orthopedic and neurological procedures are some factors propelling the growth of the market.

Despite the drivers, the high cost associated with fluoroscopic and mobile c-arm systems, the risk of radiation exposure, and presence of substitutes are some factors that are likely to hinder the growth of the market over the assessment period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7717Segment AnalysisThe global fluoroscopy and mobile c-arms market has been segmented into device type, application, and end user.

Based on application, the market has been segmented into gastrointestinal, orthopedics, pain management and trauma, cardiovascular, neurology, urology, and others.

In this region, North America is expected to dominate the market owing to the acceptance of new and innovative products, the growth in awareness about medical imaging devices, and growing financial capability to purchase expensive machines.

Europe showed a significant amount of growth in the market due to the rising incidences of road accidents leading to the increasing number of orthopedic surgeries in the European region, increased expenditure in the healthcare sector, and growing R activities.

collect
0
Emma Jackson 2020-10-13
img

Market HighlightsIt is estimated that the global microbiome sequencing services market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.

For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7532 The global microbiome sequencing services market is currently dominated by many market players.

For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator.

This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.

It is a cloud-based solution used for genomic data storage and analysis of samples.Regional AnalysisThe market in the Americas is expected to dominate the global microbiome sequencing services market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region.

These factors are expected to have a positive impact on the microbiome sequencing services market.

collect
0
Emma Jackson 2020-10-14

Market HighlightsThe Global Transcatheter Embolization and Occlusion Devices Market held a Market Value of USD 3,290.4 million in 2018 and is Projected to Grow at a CAGR of 9.9% Over the Forecast Period.

On the other hand, costlier products and the presence of stringent regulatory framework for product commercialization are anticipated to limit the market growth during the next five years.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7864Transcatheter embolization and occlusion (TEO) is a minimally invasive alternative to an open surgery thereby shifting the preference of patients towards minimally invasive surgeries as it offers several advantages including minor incisions & tissue damage, minimal pain & surgical scars, same day discharge from the healthcare settings, and speedy wound healing.

Overall, this can cause minor complications and reduces surgery costs that are likely to foster market growth during the next nine years.Technology is proving its efficiency in treatment while performing complex surgeries.

Embolization technique has become one of the most popular modalities for treatment of various types of cancer such as kidney, breast, liver (hepatocellular carcinoma), pancreatic, among others.The introduction of technically advanced products with enhanced efficiency to treat malformations and fibrosis is supporting the market growth.

For instance, in January 2018, the Cerenovus division of Johnson & Johnson Services, Inc. introduced the Galaxy G3 Mini embolic coil to remove clots from brain post ischemic strokes.Key PlayersFew of the prominent players in the global transcatheter embolization and occlusion devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Terumo Corporation, Pfizer Inc., DePuy Synthes, Cardinal Health, Cook Medical, Sirtex Medical Limited, and Merit Medical Systems.Regional AnalysisThe Global Transcatheter Embolization and Occlusion Devices Market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

These players include Stryker Corporation, Boston Scientific Corporation, Pfizer Inc., Abbott Laboratories, and Cardinal Health.Europe would follow the Americas in terms of value in the transcatheter embolization and occlusion devices market as medical devices make an essential contribution to healthcare in the European Union for the benefit of European citizens.

collect
0
Emma Jackson 2020-10-14
img

Market HighlightsThe Global Oral Anticoagulants Market is expected to grow at CAGR of 12.50% to reach USD 22,561.24 million by 2023Anticoagulant is a drug, when added to blood, prevents it from clotting.

Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood.

Increasing cardiovascular disorders, rising geriatric population, and increasing surgical procedures support the growth of the global oral anticoagulants market in recent years.

However, the high cost is likely to restrain market growth over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7718Segment AnalysisThe global oral anticoagulants market has been segmented into product, disease indication, distribution channel, and region.

On the basis of disease indication, the global oral anticoagulants market has been segmented into atrial fibrillation (AF)/ stroke prevention and deep vein thrombosis/ pulmonary embolism, and others.

This is owing to increasing cardiovascular disorders and increasing surgical procedures.

collect
0
Emma Jackson 2020-10-14
img

Market HighlightsThe global hemostasis and tissue sealing agents market is projected to grow at a CAGR of 8.6% over the forecast period.

There has been increasing demand for such products as it reduces complication during surgical procedures.

Surgeries are performed by making cut on the body which leads to the wound formation.

The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia, and Rest of Asia-Pacific.

The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others.

Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.SegmentationThe global hemostasis and tissue sealing agents’ market has been segmented into product, and end user.By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant.

collect
0
Emma Jackson 2020-10-13
img

It helps Type 1 and Type 2 diabetes patients to manage blood test results from a glucose meter, records of actual insulin delivery, statistical evaluation.

The increasing prevalence of diabetes, technological advancements, rising demand for selfcare, and involvement of major players in product launch, collaboration, and strategic merger & acquisitions are the major factors driving the growth of the global digital diabetes management market.

Additionally, increasing research and development spending by the top players are fueling the growth of the market during forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7527Regional AnalysisThe market is likely to dominate by Americas during the forecast period owing to the advancement in technology, and favorable reimbursement policies.

The European market is expected to be the second-largest due to government funding and support of the healthcare sector, coupled with increasing research and development.

Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing investments in healthcare, rising number of the diabetes patient, expansions strategy by market players in the region, and favorable government initiatives for healthcare facilities.

The market in the Middle East & Africa is likely to account for the smallest share of the global digital diabetes management market.SegmentationThe global digital diabetes management market has been segmented on the basis of type, product and services, end user, and region.On the basis of type, the market has been classified as wearable devices and handheld devices.

collect
0
Emma Jackson 2020-10-14
img

The Global Healthcare Consulting Services Market is expected to register a CAGR of 10.4% during the forecast period of 2019 to 2024.

Healthcare consulting services is an essential tool which are used in various healthcare centers.

These services help in patient management in hospitals, product launching in healthcare industry and used in data management.

It also, helps to maintain connection between the patient and healthcare staff.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7860There is a high demand of healthcare consulting services in hospitals, clinics, healthcare companies, and other healthcare facilities.

The key factors contributing for the market growth are growing awareness about the patient safety, rising demand for best practices in hospitals and healthcare centers, and rising government regulation regarding patient safety boosts the market growth.Key PlayersAccenture Consulting (US), McKinsey and Company (US), Cognizant (US), Deloitte Consulting (US), Ernst and Young (UK), Bain and Company (US), Deloitte Touche Tohmatsu Limited (US), Huron Consulting (US), KPMG (Switzerland), PWC (UK), The Boston Consulting Group (US)SegmentationThe Global Healthcare Consulting Services Market is segmented on the basis of type of service, component, application, and end user.Based on the type of service, the global healthcare consulting services market is categorized into IT consulting, digital consulting, financial consulting, operations consulting, and strategy consulting.Based on the component, the global healthcare consulting services market is segmented into services, software, and hardware.Based on application, the market is segmented into operations management, financial, population health, and clinical.Based on operations management, the market is sub segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling.

Based on population health the market is sub segmented into population risk management, patient engagement, population therapy management, and others.On the basis of finance, the market is sub segmented into revenue cycle management, fraud detection, and others.

collect
0
Emma Jackson 2020-10-14

Market HighlightsThe global healthcare information systems market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors.

The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times.

Use of health care information systems in electronic prescriptions, medication management and intelligent wearable technologies to limit lifestyle diseases, and smart robots to systemize repetitive tasks is expected to significantly reduce health care costs and boost the market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7325SegmentationThe global healthcare information systems market is segmented based on type, components, deployment, end user, and region.On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management.

The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.Regional AnalysisThe Americas leads the global healthcare information systems market.

Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure.

collect
0
Emma Jackson 2020-10-13
img

Market HighlightsThe global colorimeters market is accounted for the market value of USD 90.5 million in the year 2017 and is expected to register a CAGR of 4.6% during the forecast period.

The colorimeter is a device used for detecting color and determine the concentration of a given sample.

This instrument is widely used in clinical diagnostics labs, pharmaceutical companies, research institutes, and others end users for various purposes.Increasing dental diseases and increasing awareness about dental aesthetics are expected to drive the growth of the market.

On the other hand, the lack of skilled professionals would restrain market growth over the assessment period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7558 Regional AnalysisGeographically, the Americas is expected to dominate the global colorimeters market owing to the presence of a well-established player, increasing dental diseases, and increasing awareness about dental aesthetics.

Europe is expected to hold the second largest position in the global colorimeters market.

Asia-Pacific is expected to be the fastest growing market owing to the increasing awareness about dental aesthetics.

collect
0
Emma Jackson 2020-10-13
img

Market HighlightsThe global dental biomaterials market is expected to register an approximate CAGR of 6.2% during the forecast period, 2018–2023.

Dental biomaterials are fabricated/natural structures used in dentistry.

The rising prevalence of dental caries and increasing incidences of dental trauma produces developmental backgrounds for the global dental biomaterials market.

This can be attributed due to the cheap and quality dental services provided within the country.

Factors such as the rising prevalence of caries, high dental expenditure, and the presence of major players within the region boost the market.

The North American region is estimated to lead the market owing to the developed economies like the US, Canada, and others within the region.

collect
0
Emma Jackson 2020-10-14
img

OverviewThe global Cardiovascular information system (CVIS) market size is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR).

Implementation of the electronic health records (EHR) system can make it easy for doctors and physicians to lead to faster diagnosis of diseases.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7721Technological developments in healthcare IT has led to the launch of CVIS platforms which can be accessed remotely.

This offers scope for doctors to diagnose and prescribe accurate suggestions to patients.

Recent upgrades to CVIS has made it possible for different departments in the cardiology section to share and exchange information on a single platform.The high costs associated with CVIS which can lead to hesitation towards adoption among hospitals can pose a challenge to the market growth.Segmentation AnalysisThe cardiovascular information system (CVIS) market is segmented by component, deployment, application, and end-user.By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share.

The web/cloud-based CVIS is projected grow at fastest CAGR during the forecast period due to low capital investment and scalability of operations.

On the other hand, on-premise segment accounted for the least market share due to high expenses in maintaining servers, software, and hardware.Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others.

collect
0
Emma Jackson 2020-10-14
img

Market HighlightsThe global radiofrequency ablation devices market is expected to grow at an approximate CAGR of 11.2% during the forecast period of 2018–2023.

Factors such as the advantage of radiofrequency ablation over other ablation medical procedures, the success rate of radiofrequency are driving the growth of the market.

Moreover, complications such as acute respiratory distress syndrome where success rates are low and burning sensation at the treatment site of tissue are some of the factors hindering the growth of the market.Request Sample Copyhttps://www.marketresearchfuture.com/sample_request/7634SegmentationThe global radiofrequency ablation devices market is segmented on the basis of type, application, and region.Based on the type, the global radiofrequency ablation devices market is segmented into Unipolar radiofrequency ablation and Bipolar radiofrequency ablation.

By application, the global radiofrequency ablation devices market is categorized into Surgical Oncology, Cardiology and Cardiac Rhythm Management, Gynecology, Cosmetology, Pain ManagementRegional AnalysisThe Americas dominates the global market for radiofrequency ablation devices owing to the growing geriatric population, increase in cancer cases, an increase in clinical research within the region.

Additionally, the increasing awareness about the cardiology treatment and presence of developed economies and healthcare sector within the region drives the market growth during the forecast period.

In 2017, it was estimated that Europe stood second in the global radiofrequency ablation devices market due to the increasing prevalence of gynecology, cosmetology, pain management, and others.

collect
0
Emma Jackson 2020-10-13
img

Market OverviewThe global veterinary dental equipment market was analyzed by Market Research Future (MRFR) and it was projected that a notable CAGR of 9.5% will be attained by the market over the forecast period of 2018 to 2023.

The increasing incidence of periodontal diseases among animals is said to be one of the biggest driving factors for the global veterinary dental equipment market.

Additionally, a vast array of factors is contributing to the overall growth of the market including increasing prevalence of veterinary dental problems, rising awareness about the health of animals, advancements in technologies, and increasing spending on pet insurance.

However, the increasing cost associated with advanced dental equipment and the lack of proficient and experienced veterinarians in emerging nations can pose to be a major challenge for the global market.

The equipment segment is narrowed down into dental stations, dental x-ray systems, dental lasers, electrosurgical units, and powered units.

Lastly, the consumables segment is classified into prophy products, dental supplies, and others.By end-user, the market divides into veterinary clinics, veterinary hospitals, research & academic institutes, and others.By animal type, the market includes companion animals, large animals, and others.Regional AnalysisThe global veterinary dental equipment market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Middle East and Africa.The Americas held the highest share to lead the global veterinary dental equipment market.

collect
0
Emma Jackson 2020-10-13
img

Market HighlightsThe global fetal and neonatal care equipment market held a market value of USD 5,103 million in 2017 and is projected to grow at a CAGR of 6.8% over the forecast period.

Technological advancements and launching new innovative devices in the fetal and neonatal care equipment market are driving the market growth.

For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7511Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global fetal and neonatal care equipment market owing to the growing R budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.

Europe is expected to hold the second largest position in the global fetal and neonatal care equipment market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

The Middle East & Africa has the least share of the global fetal and neonatal care equipment market.

Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.SegmentationThe global fetal and neonatal care equipment market has been segmented into type, product, and end user.

collect
0
Emma Jackson 2020-10-14
img

OverviewVaginal sling procedures are defined as types of surgeries that can help to control stress urinary incontinence.

A new report on the global vaginal slings market, published by Market Research Future (MRFR), infers that this market could mark improvement at 3.6 % CAGR between 2017 and 2023.

In terms of value, the market can be worth USD 1,459 Mn by the end of the forecast period.Major market drivingVaginal Slings Market  factors of the global vaginal slings market include the aging female population, increasing research to discover new urinary incontinence treatment options, rising occurrence of urinary incontinence.

However, the complications caused by urinary incontinence surgery and various recent product recall can hinder the market growth.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7888Market SegmentationThe global vaginal slings market segmentation encompasses end-user, method, and product type.

MRFR’s take on the market explores various facets of the market in-depth.Regarding end-users, this market has been segmented into ambulatory surgery centers, hospitals, urogynecology clinics, and others.

The TVT segment holds the 52% market share in the global vaginal slings market.Regional SegmentationA geographical outlining of the global vaginal slings market covers Europe, The Americas (North America & Latin America), Asia Pacific, and the Middle East & Africa (MEA).During the forecast period, the Americas region is expected to hold the largest market share in the global market due to the increasing awareness and the rising prevalence of urinary incontinence among the female population.

Emma Jackson 2020-10-14
img

The Global Healthcare Consulting Services Market is expected to register a CAGR of 10.4% during the forecast period of 2019 to 2024.

Healthcare consulting services is an essential tool which are used in various healthcare centers.

These services help in patient management in hospitals, product launching in healthcare industry and used in data management.

It also, helps to maintain connection between the patient and healthcare staff.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7860There is a high demand of healthcare consulting services in hospitals, clinics, healthcare companies, and other healthcare facilities.

The key factors contributing for the market growth are growing awareness about the patient safety, rising demand for best practices in hospitals and healthcare centers, and rising government regulation regarding patient safety boosts the market growth.Key PlayersAccenture Consulting (US), McKinsey and Company (US), Cognizant (US), Deloitte Consulting (US), Ernst and Young (UK), Bain and Company (US), Deloitte Touche Tohmatsu Limited (US), Huron Consulting (US), KPMG (Switzerland), PWC (UK), The Boston Consulting Group (US)SegmentationThe Global Healthcare Consulting Services Market is segmented on the basis of type of service, component, application, and end user.Based on the type of service, the global healthcare consulting services market is categorized into IT consulting, digital consulting, financial consulting, operations consulting, and strategy consulting.Based on the component, the global healthcare consulting services market is segmented into services, software, and hardware.Based on application, the market is segmented into operations management, financial, population health, and clinical.Based on operations management, the market is sub segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling.

Based on population health the market is sub segmented into population risk management, patient engagement, population therapy management, and others.On the basis of finance, the market is sub segmented into revenue cycle management, fraud detection, and others.

Emma Jackson 2020-10-14
img

The global drug discovery informatics market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period.

Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R) expenditure, and increasing burden of chronic diseases.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7831Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth.

On the basis of region, the Americas is expected to hold higher market share over the forecast period pertaining to the presence of market value contributors, burgeoning pharmaceutical and biotechnology vertical, and rising prevalence of chronic diseases in the US and Canada.

For instance, as per statistics published by the Center for Disease Control and Prevention (CDC), about 610,000 people die due to heart disease in the US every year (one in every four deaths).Europe would follow the Americas in terms of value in the drug discovery informatics market owing to a surge in the clinical discovery ventures coupled with various activities conducted by research institutes, universities, and centers.

The federal government acts as a regulator and also insures some public employees in Germany.

The German government also proposes many healthcare programs to make citizens aware of the fatal disease.Asia-Pacific would represent the fastest market growth during the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region.The Middle East & Africa has the least share of the global drug discovery informatics market.

Emma Jackson 2020-10-14

Market HighlightsThe global healthcare information systems market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors.

The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times.

Use of health care information systems in electronic prescriptions, medication management and intelligent wearable technologies to limit lifestyle diseases, and smart robots to systemize repetitive tasks is expected to significantly reduce health care costs and boost the market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7325SegmentationThe global healthcare information systems market is segmented based on type, components, deployment, end user, and region.On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management.

The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.Regional AnalysisThe Americas leads the global healthcare information systems market.

Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure.

Emma Jackson 2020-10-14
img

Market HighlightsThe Global Fluoroscopy and Mobile C-Arms Market is expected to register a CAGR of 4.58% and is anticipated to reach USD 2,951.4 million by 2023.

Fluoroscopy and mobile c-arms systems are used in a broad range of interventional radiological procedures, especially in the treatment of conditions such as spinal cord injury, pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other disease ailments.The rising prevalence of chronic diseases, growing geriatric population, and rising adoption of fluoroscopy in orthopedic and neurological procedures are some factors propelling the growth of the market.

Despite the drivers, the high cost associated with fluoroscopic and mobile c-arm systems, the risk of radiation exposure, and presence of substitutes are some factors that are likely to hinder the growth of the market over the assessment period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7717Segment AnalysisThe global fluoroscopy and mobile c-arms market has been segmented into device type, application, and end user.

Based on application, the market has been segmented into gastrointestinal, orthopedics, pain management and trauma, cardiovascular, neurology, urology, and others.

In this region, North America is expected to dominate the market owing to the acceptance of new and innovative products, the growth in awareness about medical imaging devices, and growing financial capability to purchase expensive machines.

Europe showed a significant amount of growth in the market due to the rising incidences of road accidents leading to the increasing number of orthopedic surgeries in the European region, increased expenditure in the healthcare sector, and growing R activities.

Emma Jackson 2020-10-13
img

Market HighlightsThe global colorimeters market is accounted for the market value of USD 90.5 million in the year 2017 and is expected to register a CAGR of 4.6% during the forecast period.

The colorimeter is a device used for detecting color and determine the concentration of a given sample.

This instrument is widely used in clinical diagnostics labs, pharmaceutical companies, research institutes, and others end users for various purposes.Increasing dental diseases and increasing awareness about dental aesthetics are expected to drive the growth of the market.

On the other hand, the lack of skilled professionals would restrain market growth over the assessment period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7558 Regional AnalysisGeographically, the Americas is expected to dominate the global colorimeters market owing to the presence of a well-established player, increasing dental diseases, and increasing awareness about dental aesthetics.

Europe is expected to hold the second largest position in the global colorimeters market.

Asia-Pacific is expected to be the fastest growing market owing to the increasing awareness about dental aesthetics.

Emma Jackson 2020-10-13
img

Market HighlightsIt is estimated that the global microbiome sequencing services market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.

For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7532 The global microbiome sequencing services market is currently dominated by many market players.

For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator.

This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.

It is a cloud-based solution used for genomic data storage and analysis of samples.Regional AnalysisThe market in the Americas is expected to dominate the global microbiome sequencing services market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region.

These factors are expected to have a positive impact on the microbiome sequencing services market.

Emma Jackson 2020-10-13
img

Market HighlightsThe global dental biomaterials market is expected to register an approximate CAGR of 6.2% during the forecast period, 2018–2023.

Dental biomaterials are fabricated/natural structures used in dentistry.

The rising prevalence of dental caries and increasing incidences of dental trauma produces developmental backgrounds for the global dental biomaterials market.

This can be attributed due to the cheap and quality dental services provided within the country.

Factors such as the rising prevalence of caries, high dental expenditure, and the presence of major players within the region boost the market.

The North American region is estimated to lead the market owing to the developed economies like the US, Canada, and others within the region.

Emma Jackson 2020-10-14

Market HighlightsThe Global Transcatheter Embolization and Occlusion Devices Market held a Market Value of USD 3,290.4 million in 2018 and is Projected to Grow at a CAGR of 9.9% Over the Forecast Period.

On the other hand, costlier products and the presence of stringent regulatory framework for product commercialization are anticipated to limit the market growth during the next five years.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7864Transcatheter embolization and occlusion (TEO) is a minimally invasive alternative to an open surgery thereby shifting the preference of patients towards minimally invasive surgeries as it offers several advantages including minor incisions & tissue damage, minimal pain & surgical scars, same day discharge from the healthcare settings, and speedy wound healing.

Overall, this can cause minor complications and reduces surgery costs that are likely to foster market growth during the next nine years.Technology is proving its efficiency in treatment while performing complex surgeries.

Embolization technique has become one of the most popular modalities for treatment of various types of cancer such as kidney, breast, liver (hepatocellular carcinoma), pancreatic, among others.The introduction of technically advanced products with enhanced efficiency to treat malformations and fibrosis is supporting the market growth.

For instance, in January 2018, the Cerenovus division of Johnson & Johnson Services, Inc. introduced the Galaxy G3 Mini embolic coil to remove clots from brain post ischemic strokes.Key PlayersFew of the prominent players in the global transcatheter embolization and occlusion devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Terumo Corporation, Pfizer Inc., DePuy Synthes, Cardinal Health, Cook Medical, Sirtex Medical Limited, and Merit Medical Systems.Regional AnalysisThe Global Transcatheter Embolization and Occlusion Devices Market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

These players include Stryker Corporation, Boston Scientific Corporation, Pfizer Inc., Abbott Laboratories, and Cardinal Health.Europe would follow the Americas in terms of value in the transcatheter embolization and occlusion devices market as medical devices make an essential contribution to healthcare in the European Union for the benefit of European citizens.

Emma Jackson 2020-10-14
img

OverviewThe global Cardiovascular information system (CVIS) market size is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR).

Implementation of the electronic health records (EHR) system can make it easy for doctors and physicians to lead to faster diagnosis of diseases.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7721Technological developments in healthcare IT has led to the launch of CVIS platforms which can be accessed remotely.

This offers scope for doctors to diagnose and prescribe accurate suggestions to patients.

Recent upgrades to CVIS has made it possible for different departments in the cardiology section to share and exchange information on a single platform.The high costs associated with CVIS which can lead to hesitation towards adoption among hospitals can pose a challenge to the market growth.Segmentation AnalysisThe cardiovascular information system (CVIS) market is segmented by component, deployment, application, and end-user.By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share.

The web/cloud-based CVIS is projected grow at fastest CAGR during the forecast period due to low capital investment and scalability of operations.

On the other hand, on-premise segment accounted for the least market share due to high expenses in maintaining servers, software, and hardware.Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others.

Emma Jackson 2020-10-14
img

Market HighlightsThe Global Oral Anticoagulants Market is expected to grow at CAGR of 12.50% to reach USD 22,561.24 million by 2023Anticoagulant is a drug, when added to blood, prevents it from clotting.

Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood.

Increasing cardiovascular disorders, rising geriatric population, and increasing surgical procedures support the growth of the global oral anticoagulants market in recent years.

However, the high cost is likely to restrain market growth over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7718Segment AnalysisThe global oral anticoagulants market has been segmented into product, disease indication, distribution channel, and region.

On the basis of disease indication, the global oral anticoagulants market has been segmented into atrial fibrillation (AF)/ stroke prevention and deep vein thrombosis/ pulmonary embolism, and others.

This is owing to increasing cardiovascular disorders and increasing surgical procedures.

Emma Jackson 2020-10-14
img

Market HighlightsThe global radiofrequency ablation devices market is expected to grow at an approximate CAGR of 11.2% during the forecast period of 2018–2023.

Factors such as the advantage of radiofrequency ablation over other ablation medical procedures, the success rate of radiofrequency are driving the growth of the market.

Moreover, complications such as acute respiratory distress syndrome where success rates are low and burning sensation at the treatment site of tissue are some of the factors hindering the growth of the market.Request Sample Copyhttps://www.marketresearchfuture.com/sample_request/7634SegmentationThe global radiofrequency ablation devices market is segmented on the basis of type, application, and region.Based on the type, the global radiofrequency ablation devices market is segmented into Unipolar radiofrequency ablation and Bipolar radiofrequency ablation.

By application, the global radiofrequency ablation devices market is categorized into Surgical Oncology, Cardiology and Cardiac Rhythm Management, Gynecology, Cosmetology, Pain ManagementRegional AnalysisThe Americas dominates the global market for radiofrequency ablation devices owing to the growing geriatric population, increase in cancer cases, an increase in clinical research within the region.

Additionally, the increasing awareness about the cardiology treatment and presence of developed economies and healthcare sector within the region drives the market growth during the forecast period.

In 2017, it was estimated that Europe stood second in the global radiofrequency ablation devices market due to the increasing prevalence of gynecology, cosmetology, pain management, and others.

Emma Jackson 2020-10-14
img

Market HighlightsThe global hemostasis and tissue sealing agents market is projected to grow at a CAGR of 8.6% over the forecast period.

There has been increasing demand for such products as it reduces complication during surgical procedures.

Surgeries are performed by making cut on the body which leads to the wound formation.

The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia, and Rest of Asia-Pacific.

The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others.

Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.SegmentationThe global hemostasis and tissue sealing agents’ market has been segmented into product, and end user.By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant.

Emma Jackson 2020-10-13
img

Market OverviewThe global veterinary dental equipment market was analyzed by Market Research Future (MRFR) and it was projected that a notable CAGR of 9.5% will be attained by the market over the forecast period of 2018 to 2023.

The increasing incidence of periodontal diseases among animals is said to be one of the biggest driving factors for the global veterinary dental equipment market.

Additionally, a vast array of factors is contributing to the overall growth of the market including increasing prevalence of veterinary dental problems, rising awareness about the health of animals, advancements in technologies, and increasing spending on pet insurance.

However, the increasing cost associated with advanced dental equipment and the lack of proficient and experienced veterinarians in emerging nations can pose to be a major challenge for the global market.

The equipment segment is narrowed down into dental stations, dental x-ray systems, dental lasers, electrosurgical units, and powered units.

Lastly, the consumables segment is classified into prophy products, dental supplies, and others.By end-user, the market divides into veterinary clinics, veterinary hospitals, research & academic institutes, and others.By animal type, the market includes companion animals, large animals, and others.Regional AnalysisThe global veterinary dental equipment market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Middle East and Africa.The Americas held the highest share to lead the global veterinary dental equipment market.

Emma Jackson 2020-10-13
img

It helps Type 1 and Type 2 diabetes patients to manage blood test results from a glucose meter, records of actual insulin delivery, statistical evaluation.

The increasing prevalence of diabetes, technological advancements, rising demand for selfcare, and involvement of major players in product launch, collaboration, and strategic merger & acquisitions are the major factors driving the growth of the global digital diabetes management market.

Additionally, increasing research and development spending by the top players are fueling the growth of the market during forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7527Regional AnalysisThe market is likely to dominate by Americas during the forecast period owing to the advancement in technology, and favorable reimbursement policies.

The European market is expected to be the second-largest due to government funding and support of the healthcare sector, coupled with increasing research and development.

Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing investments in healthcare, rising number of the diabetes patient, expansions strategy by market players in the region, and favorable government initiatives for healthcare facilities.

The market in the Middle East & Africa is likely to account for the smallest share of the global digital diabetes management market.SegmentationThe global digital diabetes management market has been segmented on the basis of type, product and services, end user, and region.On the basis of type, the market has been classified as wearable devices and handheld devices.

Emma Jackson 2020-10-13
img

Market HighlightsThe global fetal and neonatal care equipment market held a market value of USD 5,103 million in 2017 and is projected to grow at a CAGR of 6.8% over the forecast period.

Technological advancements and launching new innovative devices in the fetal and neonatal care equipment market are driving the market growth.

For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7511Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global fetal and neonatal care equipment market owing to the growing R budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.

Europe is expected to hold the second largest position in the global fetal and neonatal care equipment market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

The Middle East & Africa has the least share of the global fetal and neonatal care equipment market.

Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.SegmentationThe global fetal and neonatal care equipment market has been segmented into type, product, and end user.